Sara Abouelasrar Salama

The turning away of serum amyloid A biological activities and receptor usage

J. Van Damme, S. Struyf, M. Gouwy, 2020, Immunology.

Biological Characterization of Commercial Recombinantly Expressed Immunomodulating Proteins Contaminated with Bacterial Products in the Year 2020: The SAA3 Case

P. Proost, J. Van Damme, S. Struyf, 2020, Mediators of inflammation.

Serum Amyloid A1 (SAA1) Revisited: Restricted Leukocyte-Activating Properties of Homogeneous SAA1

P. Proost, J. Van Damme, S. Struyf, 2020, Frontiers in Immunology.

The Antimicrobial Activity of Peripheral Blood Neutrophils Is Altered in Patients with Primary Ciliary Dyskinesia

M. Boon, S. Struyf, Marfa Blanter, 2021, International journal of molecular sciences.

Cytokines and serum amyloid A in the pathogenesis of hepatitis C virus infection.

J. Van Damme, M. Lavie, S. Struyf, 2019, Cytokine & growth factor reviews.

Method Matters: Effect of Purification Technology on Neutrophil Phenotype and Function

P. Proost, S. Struyf, P. E. Marques, 2022, Frontiers in Immunology.

Matrix Metalloproteinase-9-Generated COOH-, but Not NH2-Terminal Fragments of Serum Amyloid A1 Retain Potentiating Activity in Neutrophil Migration to CXCL8, With Loss of Direct Chemotactic and Cytokine-Inducing Capacity

G. Opdenakker, P. Proost, J. Van Damme, 2018, Front. Immunol..